Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer

doi:10.3748/wjg.118185

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 33

This Article

(11)

(10)

(0)

(7)

(1)

(138)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 7, 2026; 32(33): 118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185

Table 2 The relationship between urinary N1, N12-diacetylspermine and clinical features in patients with gastric cancer and those with colorectal cancer, n (%)

Clinical features	GC			CRC
Clinical features	Low (n = 21)¹	High (n = 21)¹	P value	Low (n = 32)¹	High (n = 31)¹	P value
Age			0.756	-		0.799
≤ 60	13 (61.9)	11 (52.4)		12 (37.5)	13 (41.9)
> 60	8 (38.1)	10 (47.6)		20 (62.5)	18 (58.1)
Gender			0.744	-		0.074
Male	15 (71.4)	13 (61.9)		23 (71.9)	15 (48.4)
Female	6 (28.6)	8 (38.1)		9 (28.1)	16 (51.6)
CEA (ng/mL)			1.000	-		0.133
≤ 5	13 (61.9)	13 (61.9)		19 (59.4)	12 (38.7)
> 5	8 (38.1)	8 (38.1)		13 (40.6)	19 (61.3)
CA199 (U/mL)			0.663	-		0.788
≤ 43	17 (81.0)	19 (90.5)		23 (71.9)	21 (67.7)
> 43	4 (19.0)	2 (9.5)		9 (28.1)	10 (32.3)
TNM stage			0.326	-		0.453
I + II	9 (42.9)	5 (23.8)		17 (53.1)	13 (41.9)
III + IV	12 (57.1)	16 (76.2)		15 (46.9)	18 (58.1)
Lymph node metastasis			0.505	-		0.617
Yes	13 (61.9)	16 (76.2)		15 (46.9)	17 (54.8)
No	8 (38.1)	5 (23.8)		17 (53.1)	14 (45.2)
Distant metastasis			0.028	-		0.064
Yes	5 (23.8)	13 (61.9)		7 (21.9)	14 (45.2)
No	16 (76.2)	8 (38.1)		25 (78.1)	17 (54.8)
Differentiation degrees			0.136	-		0.185
Well	2 (9.5)	1 (4.8)		4 (12.5)	2 (6.5)
Moderate	8 (38.1)	3 (14.3)		25 (78.1)	21 (67.7)
Poor	11 (52.4)	17 (80.9)		3 (9.4)	8 (25.8)

¹Urinary DiAcSpm.

GC: Gastric cancer; CRC: Colorectal cancer; DiAcSpm: N1, N12-diacetylspermine; CEA: Carcinoembryonic antigen; CA199: Carbohydrate antigen 199; TNM: Tumor-node-metastasis.

Full Size Table

Citation: Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185
URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118185.htm
DOI: https://dx.doi.org/10.3748/wjg.118185

Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185 [DOI: 10.3748/wjg.118185]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.